Generate a tailored SOP for Dr. Sabrina Galinski. Improve your application with a focused, well-structured draft.
Sabrina Galinski is a researcher focusing on Molecular and Behavioural Neurobiology at the Ludwig Maximilian University of Munich. Her work primarily investigates the molecular mechanisms underlying psychiatric diseases through various methodologies, including molecular, biochemical, and cell-biological methods. Galinski's research delves into the genetic architecture of disorders such as Schizophrenia, Bipolar Disorder, and Major Depression, emphasizing the complex interplay between genetic and environmental risk factors. Recent findings from her lab suggest a significant overlap in the genetic architecture of these conditions, and the identification of risk genes has provided further insight into common pathways that might underlie neurodevelopmental alterations. In her laboratory, she utilizes genetic mouse models and patient-derived stem cell models to study the function of risk genes and develop molecular biosensors to screen pharmacological compounds that can potentially rescue compromised cellular disease profiles. Her ongoing projects include the development of target-based, pathway-centric assays in living cells aimed at identifying genetic and chemical modulators of neuropsychiatric signaling pathways.
Administered by the Faculty of Economics. GRE is NOT required for the standard M.Sc. Economics.